deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT04273282

A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%

The D3 Study: Drug Delivery vs Drops - A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery

Sponsor: Research Insight LLC

Conditions Cataract
Interventions Dexycu intracameral dexamethasone Prednisolone Acetate
Updated 7 times since 2020 Last updated: Dec 9, 2020 Started: Dec 16, 2019 Primary completion: Nov 24, 2020 Completion: Nov 24, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cataract, this trial is completed. The trial is conducted by Research Insight LLC and has accumulated 7 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshotRecruiting~Apr 2020 – ~May 2020 · 30 days · monthly snapshotRecruiting~May 2020 – ~Aug 2020 · 3 months · monthly snapshotRecruiting~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotRecruiting~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed · Phase: PHASE2 → PHASE4

  4. Aug 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  5. May 2020 — Aug 2020 [monthly]

    Recruiting PHASE2

▶ Show 2 earlier versions

  1. Apr 2020 — May 2020 [monthly]

    Recruiting PHASE2

  2. Mar 2020 — Apr 2020 [monthly]

    Recruiting PHASE2

    First recorded

Dec 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Research Insight LLC
Data source: Research Insight LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations